Transaction DateRecipientSharesTypePriceValue
12th March 2020Barbara A Wood35,000Grant/award etc.$0.00
12th March 2020Angelos M. Stergiou95,000Grant/award etc.$0.00
12th March 2020John Thomas Burns15,000Grant/award etc.$0.00
31st December 2018Angelos M. Stergiou23,277Open or private sale$1.25$29,189.36
Galena Biopharma
Galena Biopharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.



Ticker: GALE
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1390478
Employees:
Exchange: None
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $3 M (1%)
Assets, Current: $5 M (-36%)
Assets: $15 M (-12%)
Accounts Payable, Current: $2 M (-37%)
Accrued Liabilities, Current: $2 M (0%)
Liabilities, Current: $4 M (-18%)
Liabilities: $11 M (2%)
Common Stock, Value, Issued: $7 Th (40%)
Common Stock, Shares, Issued: $7 M (32%)
Additional Paid in Capital, Common Stock: $113 M (5%)
Retained Earnings (Accumulated Deficit): $110 M (0%)
Stockholders' Equity (Parent): $4 M (-37%)
Liabilities and Equity: $15 M (-12%)
Research and Development: $2 M (-44%)